Effectiveness and safety of traditional Chinese medicine on stable chronic obstructive pulmonary disease: A systematic review and meta-analysis
- PMID: 26275654
- DOI: 10.1016/j.ctim.2015.06.015
Effectiveness and safety of traditional Chinese medicine on stable chronic obstructive pulmonary disease: A systematic review and meta-analysis
Abstract
Objective: This study was intended to evaluate the efficacy and safety of Traditional Chinese Medicine (TCM) on stable chronic obstructive pulmonary disease (COPD).
Method: A systematic review was conducted of clinical trials that compared TCM plus conventional medicine treatment versus conventional medicine treatment alone. Randomized controlled trials (RCTs) of clinical therapeutic studies on COPD by TCM were included. Searches were applied to the following electronic databases: The PubMed、 the Cochrane Library、CNKI、CBM and VIP. No blinding and language restriction was used. All trials included were analyzed according to the criteria of the Cochrane Handbook. Review Manager 5.2 software was used for data analysis.
Result: 37 randomized clinical trials enrolling 3212 patients were included. Follow-up duration ranged from 4 weeks to 1.5 years. Compared to conventional medicine treatment alone, TCM plus conventional medicine treatment showed improvement in forced expiratory volume in one second (FEV1) (MD 0.12 L; 95% CI 0.08 to 0.16), and less exacerbation (OR -0.86; 95% CI -1.13 to -0.60). TCM treatment also led to a statistically improvement in SGRQ score compared to placebo (MD -4.36; 95% CI -7.12 to -1.59). There was statistically significant difference in six-minute walk distance (MD 36.66 meters, 95% CI 24.57 to 48.74) found with TCM compared to placebo.
Conclusion: Among patients with stable COPD, TCM plus conventional medical treatment therapy might be associated with reduction risk of exacerbation, improvement of lung function, better quality of life and higher exercise capacity. The results were limited by the methodological flaws of the studies. High quality studies are needed to provide clear evidence for the future use of TCM.
Keywords: Chronic obstructive pulmonary disease; Traditional Chinese medicine; randomized controlled trials; systematic review.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
A systematic review and meta-analysis of the herbal formula Buzhong Yiqi Tang for stable chronic obstructive pulmonary disease.Complement Ther Med. 2016 Dec;29:94-108. doi: 10.1016/j.ctim.2016.09.017. Epub 2016 Sep 15. Complement Ther Med. 2016. PMID: 27912964 Review.
-
Effect of Jianpi therapy in treatment of chronic obstructive pulmonary disease: a systematic review.J Tradit Chin Med. 2013 Feb;33(1):1-8. doi: 10.1016/s0254-6272(13)60092-8. J Tradit Chin Med. 2013. PMID: 23596804 Review.
-
Traditional Chinese medicine tonifying kidney therapy (Bu shen) for stable chronic obstructive pulmonary disease: Protocol for a systematic review and meta-analysis.Medicine (Baltimore). 2018 Dec;97(52):e13701. doi: 10.1097/MD.0000000000013701. Medicine (Baltimore). 2018. PMID: 30593141 Free PMC article.
-
Effect of sequential treatment with TCM syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and AECOPD risk window.Complement Ther Med. 2016 Dec;29:109-115. doi: 10.1016/j.ctim.2016.09.009. Epub 2016 Sep 13. Complement Ther Med. 2016. PMID: 27912934 Clinical Trial.
-
Tonifying kidney therapy for stable chronic obstructive pulmonary disease: a systematic review.J Tradit Chin Med. 2020 Apr;40(2):188-196. J Tradit Chin Med. 2020. PMID: 32242384
Cited by
-
Further Refinement is Required for Patient-Reported Outcome Scales for Respiratory Diseases Based on Traditional Chinese Medicine Theory for Applicability.Int J Gen Med. 2023 Dec 23;16:6099-6113. doi: 10.2147/IJGM.S438297. eCollection 2023. Int J Gen Med. 2023. PMID: 38152077 Free PMC article. Review.
-
Effective-compound combination of Bufei Yishen formula III combined with ER suppress airway mucus hypersecretion in COPD rats: via EGFR/MAPK signaling.Biosci Rep. 2023 Nov 30;43(11):BSR20222669. doi: 10.1042/BSR20222669. Biosci Rep. 2023. PMID: 36799253 Free PMC article.
-
Effects of Ipratropium Bromide Combined with Traditional Chinese Medicine Intervention on the Pulmonary Function and Psychological Status of Patients with Chronic Obstructive Pulmonary Disease.Evid Based Complement Alternat Med. 2023 Feb 7;2023:6483785. doi: 10.1155/2023/6483785. eCollection 2023. Evid Based Complement Alternat Med. 2023. PMID: 36798728 Free PMC article.
-
Herb Formula (GCis) Prevents Pulmonary Infection Secondary to Intracerebral Hemorrhage by Enhancing Peripheral Immunity and Intestinal Mucosal Immune Barrier.Front Pharmacol. 2022 May 23;13:888684. doi: 10.3389/fphar.2022.888684. eCollection 2022. Front Pharmacol. 2022. PMID: 35677425 Free PMC article.
-
Efficacy and safety of modified Bushen Yiqi formulas (MBYF) as an add-on to formoterol and budesonide in the management of COPD: study protocol for a multicentre, double-blind, placebo-controlled, parallel-group, randomized clinical trial: FB-MBYF Trial.Trials. 2022 Feb 14;23(1):143. doi: 10.1186/s13063-022-06057-7. Trials. 2022. PMID: 35164853 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
